118 related articles for article (PubMed ID: 2508202)
1. Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
Salfinger M; Reller LB; Demchuk B; Johnson ZT
Res Microbiol; 1989; 140(4-5):301-9. PubMed ID: 2508202
[TBL] [Abstract][Full Text] [Related]
2. Comparison of growth and susceptibility testing of pyrazinamide in different Bactec media using strains of the M. tuberculosis complex.
Fuursted K
APMIS; 1993 Feb; 101(2):154-9. PubMed ID: 8489766
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test.
Aono A; Hirano K; Hamasaki S; Abe C
Diagn Microbiol Infect Dis; 2002 Dec; 44(4):347-52. PubMed ID: 12543539
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
Aragón LM; Garrigó M; Moreno C; Español M; Coll P
J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
[TBL] [Abstract][Full Text] [Related]
5. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method.
Salfinger M; Heifets LB
Antimicrob Agents Chemother; 1988 Jul; 32(7):1002-4. PubMed ID: 3142340
[TBL] [Abstract][Full Text] [Related]
6. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
Pina RZ; Caleffi-Ferracioli KR; Campanerut-Sá PA; Ghiraldi-Lopez LD; Pavan FR; Siqueira VL; Scodro RB; Cardoso RF
Int J Tuberc Lung Dis; 2016 Nov; 20(11):1535-1538. PubMed ID: 27776597
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
Tarrand JJ; Spicer AD; Gröschel DH
Antimicrob Agents Chemother; 1986 Dec; 30(6):852-5. PubMed ID: 3101586
[TBL] [Abstract][Full Text] [Related]
8. [Determination of pyrazinamide susceptibility for Mycobacterium tuberculosis by use of Middlebrook culture media and comparison with results of pyrazinamidase test].
Yamane N; Nakasone I; Yamashita K; Toyoda K; Okazawa Y
Rinsho Byori; 1998 May; 46(5):479-85. PubMed ID: 9627500
[TBL] [Abstract][Full Text] [Related]
9. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
Ozkütük N; Ecemiş T; Sürücüoğlu S
Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
[TBL] [Abstract][Full Text] [Related]
10. Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis?
Heifets LB; Flory MA; Lindholm-Levy PJ
Antimicrob Agents Chemother; 1989 Aug; 33(8):1252-4. PubMed ID: 2508544
[TBL] [Abstract][Full Text] [Related]
11. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
[TBL] [Abstract][Full Text] [Related]
12. Pyrazinamide is not active in vitro against Mycobacterium avium complex.
Heifets LB; Iseman MD; Crowle AJ; Lindholm-Levy PJ
Am Rev Respir Dis; 1986 Dec; 134(6):1287-8. PubMed ID: 3789528
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test.
Miller MA; Thibert L; Desjardins F; Siddiqi SH; Dascal A
J Clin Microbiol; 1996 Jan; 34(1):84-6. PubMed ID: 8748279
[TBL] [Abstract][Full Text] [Related]
14. Is pyrazinamide bactericidal against Mycobacterium tuberculosis?
Heifets LB; Lindholm-Levy PJ
Am Rev Respir Dis; 1990 Jan; 141(1):250-2. PubMed ID: 2105072
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
[TBL] [Abstract][Full Text] [Related]
16. [A study of the bacteriophage-based assay for the detection of pyrazinamide resistance in Mycobacterium tuberculosis].
Ao JP; Chen JW; Hu ZY; Li JN; Wang J; Wang Q; Cui ZL; Zhang WH; Wong XH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):625-8. PubMed ID: 17129472
[TBL] [Abstract][Full Text] [Related]
17. Detection of pyrazinamide resistance of Mycobacterium tuberculosis using nicotinamide as a surrogate.
Hu Y; Wu X; Luo J; Fu Y; Zhao L; Ma Y; Li Y; Liang Q; Shang Y; Huang H
Clin Microbiol Infect; 2017 Nov; 23(11):835-838. PubMed ID: 28411185
[TBL] [Abstract][Full Text] [Related]
18. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
[TBL] [Abstract][Full Text] [Related]
19. Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system.
Salfinger M; Crowle AJ; Reller LB
J Infect Dis; 1990 Jul; 162(1):201-7. PubMed ID: 2113074
[TBL] [Abstract][Full Text] [Related]
20. Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains.
Dormandy J; Somoskovi A; Kreiswirth BN; Driscoll JR; Ashkin D; Salfinger M
Chest; 2007 Feb; 131(2):497-501. PubMed ID: 17296653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
